全文获取类型
收费全文 | 17062篇 |
免费 | 957篇 |
国内免费 | 139篇 |
专业分类
耳鼻咽喉 | 139篇 |
儿科学 | 397篇 |
妇产科学 | 355篇 |
基础医学 | 1849篇 |
口腔科学 | 460篇 |
临床医学 | 1851篇 |
内科学 | 3949篇 |
皮肤病学 | 206篇 |
神经病学 | 1786篇 |
特种医学 | 492篇 |
外科学 | 2364篇 |
综合类 | 73篇 |
现状与发展 | 1篇 |
一般理论 | 12篇 |
预防医学 | 1304篇 |
眼科学 | 353篇 |
药学 | 943篇 |
中国医学 | 22篇 |
肿瘤学 | 1602篇 |
出版年
2024年 | 14篇 |
2023年 | 142篇 |
2022年 | 283篇 |
2021年 | 544篇 |
2020年 | 302篇 |
2019年 | 506篇 |
2018年 | 548篇 |
2017年 | 440篇 |
2016年 | 425篇 |
2015年 | 502篇 |
2014年 | 741篇 |
2013年 | 915篇 |
2012年 | 1314篇 |
2011年 | 1430篇 |
2010年 | 730篇 |
2009年 | 666篇 |
2008年 | 1215篇 |
2007年 | 1193篇 |
2006年 | 1065篇 |
2005年 | 1061篇 |
2004年 | 1002篇 |
2003年 | 887篇 |
2002年 | 802篇 |
2001年 | 106篇 |
2000年 | 79篇 |
1999年 | 110篇 |
1998年 | 144篇 |
1997年 | 114篇 |
1996年 | 105篇 |
1995年 | 105篇 |
1994年 | 77篇 |
1993年 | 68篇 |
1992年 | 47篇 |
1991年 | 42篇 |
1990年 | 46篇 |
1989年 | 42篇 |
1988年 | 33篇 |
1987年 | 29篇 |
1986年 | 26篇 |
1985年 | 30篇 |
1984年 | 26篇 |
1983年 | 33篇 |
1982年 | 32篇 |
1981年 | 21篇 |
1980年 | 19篇 |
1979年 | 21篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1975年 | 6篇 |
1974年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
Michele Masellis 《European journal of plastic surgery》1990,13(4):188-188
Forthcoming meetings &; events 相似文献
32.
Edward Stepanski Michele Glinn Frank Zorick Timothy Roehrs Thomas Roth 《Stress and health》1994,10(4):261-266
This study assessed physiological activity in patients with chronic insomnia before sleep, during sleep and in response to acute stress. Twenty-four subjects with chronic insomnia and 25 normal sleepers slept in the laboratory overnight and were given a stressful performance task in the morning. Heart rate was significantly higher in the insomniac group at night. The next morning, heart rate was not different at baseline, but was significantly higher during the performance task in the insomniac group. These results are discussed as supporting the notion that insomniacs have greater physiological responsivity to stress. Further research is needed to determine if altered physiological activity is a cause or consequence of insomnia. 相似文献
33.
Multiple sclerosis (MS) is a highly variable, unpredictable disease and one of the most life-altering diagnoses a person can receive. Because it usually strikes in the prime of life, frequently progresses to disability, and has no cure, MS can make a strong emotional impact--not only on those who suffer from it, but also the healthcare team. Because MS is such a complex, multifaceted disorder, nurses who care for people with MS are faced with numerous clinical challenges. Many of the challenges are unique to MS, demanding, and time-consuming. Well-informed nurses are positioned to evaluate and explain the disease process, assist in the alleviation of symptoms, educate partners and families, and help improve quality of life. A case example can help nurses understand the real-life concerns of a person with MS. 相似文献
34.
35.
Roberto Valcavi Michele Zini Simona Davoli Italo Portionli 《Clinical endocrinology》1992,37(4):360-364
OBJECTIVE: We have investigated the late GH rise occurring 3-5 hours after oral glucose administration. We have assessed the effect of endogenous cholinergic enhancement with pyridostigmine on the delayed GH rise following oral glucose loading in normal subjects. DESIGN: Placebo or 75 g oral glucose was given to the normal subjects 3 hours before 120 mg oral pyridostigmine or placebo. Four tests were carried out at random. (0 min) + placebo (180 min); test 2: glucose (0 min) + placebo (180 min); test 3: placebo (0 min) + pyridostigmine (180 min); test 4: glucose (0 min) + pyridostigmine (180 min). SUBJECTS: We studied eight normal subjects (four male and four female), ages 19-29 years, body mass indices 18-22 kg/m2. MEASUREMENTS: Plasma glucose and serum GH concentrations were measured for 6 hours after oral glucose or placebo administration. RESULTS: Pyridostigmine treatment significantly enhanced the GH releasing effect of prior (3 h) oral glucose. Late GH peak obtained by oral glucose loading rose from (mean +/- SEM) 17.4 +/- 4.6 to 37.2 +/- 9.0 mU/l (P < 0.05) after pyridostigmine, while GH peak following placebo plus pyridostigmine was 12.4 +/- 2.0 mU/l (P < 0.05 vs glucose plus pyridostigmine). The analysis of GH area under curves (AUCs) in the second phase of the tests (180-360 min) confirmed that glucose plus pyridostigmine released a greater amount of GH (4128 +/- 764 mU/l/3h) than glucose (1694 +/- 494 mU/l/3h, P < 0.001) or pyridostigmine alone (1292 +/- 150 mU/I/3h, P < 0.001). CONCLUSIONS: Pyridostigmine, an indirect cholinergic drug likely to inhibit somatostatin secretion from the hypothalamus, enhanced the late GH releasing activity of oral glucose. There is evidence that glucose suppresses plasma GH initially by increasing hypothalamic somatostatin release. This would result in an increase in the pituitary stores of GH. We propose that the delayed GH rise after oral glucose occurs when there is a fall in hypothalamic somatostatinergic tone; this is further reduced by the administration of pyridostigmine. At this time the pituitary stores of GH are released as a consequence of resumption of hypothalamic GHRH activity. This leads to the late GH rise. 相似文献
36.
John D. England Fabia Gamboni Michele A. Ferguson S. Rock Levinson 《Muscle & nerve》1994,17(6):593-598
The axolemmal distribution of voltage-gated sodium channels largely determines the regions of axonal electrical excitability. Using a wellcharacterized anti–sodium channel antibody, we examined peripheral nerve fibers focally injured by exposure to the neurotoxic agent, potassium tellurite (K2TeO3). Immunocytochemical and radioimmunoassay data showed a focal accumulation of sodium channels within the tips of injured axons. The major increase in sodium channel concentration occurred between 7 and 11 days after toxin exposure; however, immunocytochemically, excess sodium channels persisted in several axonal endings for a much longer time. The accumulation of sodium channels at injured axonal tips may be responsible, in part, for ectopic axonal excitability and the resulting abnormal sensory phenomena (especially pain and paresthesias) which frequently complicate peripheral nerve injury in humans. © 1994 John Wiley & Sons, Inc. 相似文献
37.
Gangliosides of cultured astroglia 总被引:3,自引:0,他引:3
Michele Sbaschnig-Agler Henri Dreyfus William T. Norton Monique Sensenbrenner Muhammad Farooq Mary C. Byrne Robert W. Ledeen 《Brain research》1988,461(1):98-106
Cultured astrocytes prepared from newborn rat brain and 13-day-old chick embryonic brain were analyzed qualitatively and quantitatively for ganglioside content. All preparations contained approximately the same total level: 2.4-3.4 micrograms N-acetylneuraminic acid (NeuAc)/mg protein. In contrast, the value for primary cultures of neurons from chick embryonic brain was 5.9. The non-hexosamine-containing species, GM3 and GD3, comprised 75-85% of the total in astroglial cultures, the remainder consisting mainly of structural types other than the gangliotetraose series; choleragenoid assay revealed the latter to be virtually absent or to comprise at most a few percent. Deficiency of gangliotetraose synthesizing ability was indicated by the very low level of UDP-GalNac:GM3 N-acetylgalactosaminyltransferase detected in the cells. Treatment of cultured astrocytes with astroglial growth factor 2 or dibutyryl cyclic AMP caused little if any change in quantity or pattern of gangliosides. The large majority of cells stained in a manner characteristic of astrocytes: positive for glial fibrillary acidic protein, negative for galactosyl ceramides. Staining with cholera toxin and anti-GM1 antibody was essentially negative, as was that with tetanus toxin, A2B5 monoclonal antibody, and antibody to GD3. All evidence thus points to cultured astrocytes of rat and chick brain containing appreciable gangliosides, most of which are GM3 and GD3 with the majority of the remainder comprising structures other than the gangliotetraose type. 相似文献
38.
Dr. Michele Musci MD H. Siniawski MD PhD C. Knosalla MD PhD O. Grauhan MD PhD Y. Weng MD PhD M. Pasic MD PhD R. Meyer MD PhD R. Hetzer MD PhD 《Clinical research in cardiology》2006,95(5):247-253
Summary
Aims This study investigated the early and mid–term results following valve replacement with the new Shelhigh? stentless bioprosthesis made entirely of biological material in patients with active infective endocarditis (AIE).
Material and methods Between 02/2000 and 12/2004, 164 patients (n = 122 men, mean age 59, 18–85 years) received implantation of an AIE Shelhigh? stentless bioprosthesis in the aortic, mitral, tricuspid or pulmonary position. A total of 119 patients (72.6%) had native
AIE and 45 (27.4%) prosthetic AIE. A large proportion of the patients reached the operating room in a condition of cardiac
decompensation: 37 (22.6%) patients were intubated, 40 (24.4%) had protracted septic shock and 41 (25.0%) required intensive
catecholamine treatment. Surgery was regarded as urgent in 94 patients (57.4%) and was performed as an emergency procedure
in 70 (42.6%). The mean follow–up time is 1.5 ± 0.11 years (range, 5 months to 5.2 years). Echocardiographic follow–up examinations
were performed early postoperatively and after 12 months.
Results In terms of the operative indication, we found a highly significant difference in the survival rate between patients who were
operated on urgently vs in an emergency. In patients who died within 30 days, the main cause of death was septic multiorgan
failure (67.6%). Only three patients required reoperation due to reinfection of the Shelhigh? bioprostheses; this represents a reinfection rate of 1.8% in relation to the whole cohort. The postoperative echocardiographic
examinations showed the Shelhigh? valves to have very good hemodynamics without relevant pressure gradients.
Conclusion Our experience in the use of Shelhigh? bioprostheses in patients with native and prosthetic endocarditis show the early and mid–term results, in particular the
low reinfection rate and the good hemodynamics, to be comparable with the results achieved using homografts. Since these prostheses
are readily available and their implantation straightforward, they are increasingly being used in patients with endocarditis.
These promising results need to verified in the long term.
This paper was presented at a lecture held at the 71st annual meeting of the German Society for Cardiology, Mannheim, 31. March—2. April 2005.
Disclosure Form: The following study discloses my relationship with any corporate sponsor that might relate in some way to
the subject presented. 相似文献
39.
40.
Reported are two cases of video-PSG captured head-rolling occurring, in the context of REM Sleep Behavior Disorder (RBD) episodes, in two patients affected with idiopathic RBD and without past personal or familiar history of Rhythmic Movement Disorder during sleep. It has been speculated that the activation of neuronal pathways which underlie REM-related loss of motor control in RBD, may involve the Central Pattern Generator neuronal networks leading to the induction of Rhythmic Movements during RBD episodes, thereby allowing the re-emergence, in pathological conditions in later life, of a motor behavior typically seen in the early stage of life. 相似文献